Digital Edition

Best Practices in Hematology and Oncology (February 2018)


 

Recommended Reading

Late-breaking abstracts highlight treatment advances in CLL, myeloma, and more
AVAHO
Double Vision From a Rare Gastrointestinal Tumor
AVAHO
Higher Risk of Secondary Cancers for Patients With Mycosis Fungoides
AVAHO
Hydrochlorothiazide use linked to higher skin cancer risk
AVAHO
Continue to opt for HDT/ASCT for multiple myeloma
AVAHO
VA Central California Improves Access to Clinical Trials
AVAHO
Can Albumin/Globulin Levels Predict Digestive Cancer Prognosis?
AVAHO
Uncovering Clues That Explain the Ototoxicity of Cisplatin
AVAHO
CLL drug in limited supply outside U.S.
AVAHO
Rituximab Still Proves Safe Long Term
AVAHO